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Letters to the Editor 
Reader Disagrees With 
Contaminated Field Advice 
we with the advice given in the January I 1988 “Clinical Issues” column regarding contam- 
ination of the sterile field. The author d m i  
a scenario involving a contaminated suture packet 
that landed on a corner of the sterile setup. The 
response stated that “the whole setup became 
contaminated.” How? If the packet only contacted 
one corner of the setup, then only that corner 
is contaminated. Microorganisms can not jump 
from one place to another. If the scrub nurse 
covered the involved area without contacting the 
packet, then the rest of the setup is safe to use. 
If, however, the scrub nurse touched the packet 
and subsequently touched other areas of the setup, 
then the entire setup should be replaced. 
We must have clinical practice based on 
scientific principles, rather than perpetuating rituals 
that have no scientific basis. 
SANDRA J. PFAFF, RN, BSN, CIC 
INFECTION CONTROL NURSE 
ROCHESTER, NY 
UNIVERSITY OF ROCHESTER MEDICAL CENTER 
Author’s respnse. In the AORN “Recommended 
practices for basic aseptic technique,” recom- 
mended practice 111 reads “all items used within 
a sterile field should be sterile.”’ In the same 
recommended practice, one rationale states that 
“only sterile items touch sterile surfaces.”* 
Using both of these statements and the logic 
of a “surgical conscience” as a guideline, the nurse 
must believe that once a sterile field is contam- 
inated, the entire field is considered unsterile. The 
short time involved in replacing the sterile setup 
and the cost of surgical supplies is minimal 
compared to the potential outcome and cost of 
surgical wound infection. 
ROSEMARY ANN ROTH, RN, MSN, CNOR 





1. “Recommended practices for basic aseptic 
technique,” in AORN Standards and Recommended 
Practices for Perioperative Nursing (Denver: Associ- 
ation of Operating Room Nurses, Inc, 1988) III:2-2. 
2. Ibid 1112-3. 
More on Prosthetic Fingernails 
read with interest the article entitled, “Prosthetic I fingernails in the OR A research study,” in 
the April issue of the JournaL I would like to 
share the conclusions of an unpublished scientific 
paper entitled, “Semi-quantitative comparison of 
bacterial colonization levels of artificial nails versus 
natural nails before and after handwashing,” which 
was presented at the Association for Practitioners 
in Infection Control 14th Annual Educational 
Conference on May 7, 1987, in Miami Beach, 
Fla. 
The authors, J. Pattinger, RN, BSN; S. Bums, 
RN, BSN, and C. Manske, MT, conducted a study 
to measure bacterial colonization on artificial and 
natural nails and to compare the levels of 
colonization between the two groups. The sample 
consisted of 50 nurses with artificial nails paired 
with 50 nurses with natural nails from the same 
patient care areas. Cultures were obtained by 
agitating the fingertips of the dominant hand in 
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thioglycollate broth. Next, a timed 10-second 
handwash was observed and repeated cultures of 
the fingertips were obtained for comparison. 
Culture media was plated within 12 hours. 
The author’s results showed that nurses with 
artificial nails had a higher number of colony- 
forming units (CFUs) of microorganisms as 
compared to nurses with natural nails (225 CFUs 
compared to 175 CFUs before handwashing; 375 
CFUs compared to 340 CFUs after handwashing). 
Gram negative organisms were significantly 
increased in artificial nail wearers and increased 
after handwashing. Artificial nails were longer 
(greater than 0.5 mm) than natural nails for a 
significant p value of 0.001. 
Based on the results of the study, the authors 
concluded that the use of artificial nails including 
nail wraps, acrylics, and tips should be restricted 
to health care workers not involved in direct 
patient care. 
JOLE MOWRY-HANLEY, RN, CIC 
STAFF SPECIALIST 
INFECTION CONTROL SERVICES 
ANN ARBOR, MICH 
UNIVERSITY OF MICHIGAN HOSPITALS 
Author’s response. I believe that the stated 
conclusion is not substantiated by the results given 
in Ms Mowry-Hanley’s letter. The only p value 
given, which is necessary to know for statistical 
significance, is one showing that artificial nails 
were longer than natural nails. This statement is 
irrelevant to the research question. 
The authors of the study quoted by Ms Mowry- 
Hanley also state that gram negative organisms 
were significantly increased, but where are the 
data to substantiate this statement? Stating that 
colony counts were higher in one group than the 
other is not enough. The question is: Is there a 
statistically significant difference? 
I believe that this study (as presented in the 
letter) along with the article in the April issue 
of the Journal, “Prosthetic fingernails in the OR 
A research study,” show a trend only. This is 
not enough to draw the conclusion that artificial 
nails should not be worn by health care workers 
giving direct patient care. Further research is 
needed to support that statement. 
DEBORAH RUBIN, RN, CNOR 
PERIOPERATIVE NURSE EDUCATOR 
UNIVERSITY OF CALIFORNIA 
SAN FRANCISCO H SPITALS AND CLINICS 
The Journal welcomes letters for its “Letters to the 
Editor” column Letters must refer to Journal articles 
or columns publkhed within the preceding two months. 
Each letter k subject to editing. Authors of articles or 
columns referenced in the letter to the editor will be 
given the opportunity to respond 
Letters that are included in the ‘Zetters to the Editor” 
column must contain the reader’s name, credentiab if 
applicable (eg, RN, BSN, CNOR), position or title, 
employer, and employer’s d r e s s .  Submit all corres- 
pondence to AORN Journal, Lettersto the Editor, 101 70 
East Mksksippi A ve., Denver, CO 80231. 
SAN FRANCISCO 
Isotretinoin Should 
Stay on Market 
An advisory committee to the Food and Drug 
Administration (FDA) unanimously recom- 
mended that isotretinoin (Accutanee) remain on 
the market despite a recent report linking the 
drug with thousands of birth defects. The com- 
mittee advised the FDA to require stronger 
warnings on the drug, which is used to treat 
recalcitrant cystic acne, and to require women of 
child-bearing age to test negatively for pregnancy 
before using it. 
Three FDA scientists previously recom- 
mended that the drug be taken off the market 
because they believe it caused between 900 and 
1,300 birth defects and between 700 and 1,OOO 
spontaneous abortions. 
Officials at a manufacturer of the drug claim 
that those estimates are flawed and that the 
number of birth defects attributable to the use of 
the drug is closer to the 62 officially reported to 
the FDA. 
Leading dermatologists also do not believe 
that the amount of damage caused by the drug 
and the number of prescriptions written inap 
propriately or for pregnant women could be any- 
where near the numbers reported by the three 
scientists. 
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